The global Mobile Cardiac Telemetry Device market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Mobile Cardiac Telemetry Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Mobile Cardiac Telemetry Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Mobile Cardiac Telemetry Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Mobile Cardiac Telemetry Device players cover BioTelemetry, Inc., ScottCare, Biotricity, Inc., Welch Allyn, Applied Cardiac Systems, Inc., Medicomp, Inc., Preventice Solutions, Telerhythmics LLC and Zoll Medical Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Mobile Cardiac Telemetry Device Industry Forecast” looks at past sales and reviews total world Mobile Cardiac Telemetry Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Mobile Cardiac Telemetry Device sales for 2023 through 2029. With Mobile Cardiac Telemetry Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mobile Cardiac Telemetry Device industry.
This Insight Report provides a comprehensive analysis of the global Mobile Cardiac Telemetry Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mobile Cardiac Telemetry Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Mobile Cardiac Telemetry Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mobile Cardiac Telemetry Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mobile Cardiac Telemetry Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Mobile Cardiac Telemetry Device market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Lead-based
Patch-based
Segmentation by application
Hospitals
Specialty Clinics
Diagnostic Centers
Home Care Settings
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BioTelemetry, Inc.
ScottCare
Biotricity, Inc.
Welch Allyn
Applied Cardiac Systems, Inc.
Medicomp, Inc.
Preventice Solutions
Telerhythmics LLC
Zoll Medical Corporation
iRhythm Technologies, Inc.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Mobile Cardiac Telemetry Device market?
What factors are driving Mobile Cardiac Telemetry Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mobile Cardiac Telemetry Device market opportunities vary by end market size?
How does Mobile Cardiac Telemetry Device break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Mobile Cardiac Telemetry Device Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Mobile Cardiac Telemetry Device by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Mobile Cardiac Telemetry Device by Country/Region, 2018, 2022 & 2029 2.2 Mobile Cardiac Telemetry Device Segment by Type 2.2.1 Lead-based 2.2.2 Patch-based 2.3 Mobile Cardiac Telemetry Device Sales by Type 2.3.1 Global Mobile Cardiac Telemetry Device Sales Market Share by Type (2018-2023) 2.3.2 Global Mobile Cardiac Telemetry Device Revenue and Market Share by Type (2018-2023) 2.3.3 Global Mobile Cardiac Telemetry Device Sale Price by Type (2018-2023) 2.4 Mobile Cardiac Telemetry Device Segment by Application 2.4.1 Hospitals 2.4.2 Specialty Clinics 2.4.3 Diagnostic Centers 2.4.4 Home Care Settings 2.4.5 Others 2.5 Mobile Cardiac Telemetry Device Sales by Application 2.5.1 Global Mobile Cardiac Telemetry Device Sale Market Share by Application (2018-2023) 2.5.2 Global Mobile Cardiac Telemetry Device Revenue and Market Share by Application (2018-2023) 2.5.3 Global Mobile Cardiac Telemetry Device Sale Price by Application (2018-2023) 3 Global Mobile Cardiac Telemetry Device by Company 3.1 Global Mobile Cardiac Telemetry Device Breakdown Data by Company 3.1.1 Global Mobile Cardiac Telemetry Device Annual Sales by Company (2018-2023) 3.1.2 Global Mobile Cardiac Telemetry Device Sales Market Share by Company (2018-2023) 3.2 Global Mobile Cardiac Telemetry Device Annual Revenue by Company (2018-2023) 3.2.1 Global Mobile Cardiac Telemetry Device Revenue by Company (2018-2023) 3.2.2 Global Mobile Cardiac Telemetry Device Revenue Market Share by Company (2018-2023) 3.3 Global Mobile Cardiac Telemetry Device Sale Price by Company 3.4 Key Manufacturers Mobile Cardiac Telemetry Device Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Mobile Cardiac Telemetry Device Product Location Distribution 3.4.2 Players Mobile Cardiac Telemetry Device Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Mobile Cardiac Telemetry Device by Geographic Region 4.1 World Historic Mobile Cardiac Telemetry Device Market Size by Geographic Region (2018-2023) 4.1.1 Global Mobile Cardiac Telemetry Device Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Mobile Cardiac Telemetry Device Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Mobile Cardiac Telemetry Device Market Size by Country/Region (2018-2023) 4.2.1 Global Mobile Cardiac Telemetry Device Annual Sales by Country/Region (2018-2023) 4.2.2 Global Mobile Cardiac Telemetry Device Annual Revenue by Country/Region (2018-2023) 4.3 Americas Mobile Cardiac Telemetry Device Sales Growth 4.4 APAC Mobile Cardiac Telemetry Device Sales Growth 4.5 Europe Mobile Cardiac Telemetry Device Sales Growth 4.6 Middle East & Africa Mobile Cardiac Telemetry Device Sales Growth 5 Americas 5.1 Americas Mobile Cardiac Telemetry Device Sales by Country 5.1.1 Americas Mobile Cardiac Telemetry Device Sales by Country (2018-2023) 5.1.2 Americas Mobile Cardiac Telemetry Device Revenue by Country (2018-2023) 5.2 Americas Mobile Cardiac Telemetry Device Sales by Type 5.3 Americas Mobile Cardiac Telemetry Device Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Mobile Cardiac Telemetry Device Sales by Region 6.1.1 APAC Mobile Cardiac Telemetry Device Sales by Region (2018-2023) 6.1.2 APAC Mobile Cardiac Telemetry Device Revenue by Region (2018-2023) 6.2 APAC Mobile Cardiac Telemetry Device Sales by Type 6.3 APAC Mobile Cardiac Telemetry Device Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Mobile Cardiac Telemetry Device by Country 7.1.1 Europe Mobile Cardiac Telemetry Device Sales by Country (2018-2023) 7.1.2 Europe Mobile Cardiac Telemetry Device Revenue by Country (2018-2023) 7.2 Europe Mobile Cardiac Telemetry Device Sales by Type 7.3 Europe Mobile Cardiac Telemetry Device Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Mobile Cardiac Telemetry Device by Country 8.1.1 Middle East & Africa Mobile Cardiac Telemetry Device Sales by Country (2018-2023) 8.1.2 Middle East & Africa Mobile Cardiac Telemetry Device Revenue by Country (2018-2023) 8.2 Middle East & Africa Mobile Cardiac Telemetry Device Sales by Type 8.3 Middle East & Africa Mobile Cardiac Telemetry Device Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Mobile Cardiac Telemetry Device 10.3 Manufacturing Process Analysis of Mobile Cardiac Telemetry Device 10.4 Industry Chain Structure of Mobile Cardiac Telemetry Device 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Mobile Cardiac Telemetry Device Distributors 11.3 Mobile Cardiac Telemetry Device Customer 12 World Forecast Review for Mobile Cardiac Telemetry Device by Geographic Region 12.1 Global Mobile Cardiac Telemetry Device Market Size Forecast by Region 12.1.1 Global Mobile Cardiac Telemetry Device Forecast by Region (2024-2029) 12.1.2 Global Mobile Cardiac Telemetry Device Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Mobile Cardiac Telemetry Device Forecast by Type 12.7 Global Mobile Cardiac Telemetry Device Forecast by Application 13 Key Players Analysis 13.1 BioTelemetry, Inc. 13.1.1 BioTelemetry, Inc. Company Information 13.1.2 BioTelemetry, Inc. Mobile Cardiac Telemetry Device Product Portfolios and Specifications 13.1.3 BioTelemetry, Inc. Mobile Cardiac Telemetry Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 BioTelemetry, Inc. Main Business Overview 13.1.5 BioTelemetry, Inc. Latest Developments 13.2 ScottCare 13.2.1 ScottCare Company Information 13.2.2 ScottCare Mobile Cardiac Telemetry Device Product Portfolios and Specifications 13.2.3 ScottCare Mobile Cardiac Telemetry Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 ScottCare Main Business Overview 13.2.5 ScottCare Latest Developments 13.3 Biotricity, Inc. 13.3.1 Biotricity, Inc. Company Information 13.3.2 Biotricity, Inc. Mobile Cardiac Telemetry Device Product Portfolios and Specifications 13.3.3 Biotricity, Inc. Mobile Cardiac Telemetry Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Biotricity, Inc. Main Business Overview 13.3.5 Biotricity, Inc. Latest Developments 13.4 Welch Allyn 13.4.1 Welch Allyn Company Information 13.4.2 Welch Allyn Mobile Cardiac Telemetry Device Product Portfolios and Specifications 13.4.3 Welch Allyn Mobile Cardiac Telemetry Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Welch Allyn Main Business Overview 13.4.5 Welch Allyn Latest Developments 13.5 Applied Cardiac Systems, Inc. 13.5.1 Applied Cardiac Systems, Inc. Company Information 13.5.2 Applied Cardiac Systems, Inc. Mobile Cardiac Telemetry Device Product Portfolios and Specifications 13.5.3 Applied Cardiac Systems, Inc. Mobile Cardiac Telemetry Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Applied Cardiac Systems, Inc. Main Business Overview 13.5.5 Applied Cardiac Systems, Inc. Latest Developments 13.6 Medicomp, Inc. 13.6.1 Medicomp, Inc. Company Information 13.6.2 Medicomp, Inc. Mobile Cardiac Telemetry Device Product Portfolios and Specifications 13.6.3 Medicomp, Inc. Mobile Cardiac Telemetry Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Medicomp, Inc. Main Business Overview 13.6.5 Medicomp, Inc. Latest Developments 13.7 Preventice Solutions 13.7.1 Preventice Solutions Company Information 13.7.2 Preventice Solutions Mobile Cardiac Telemetry Device Product Portfolios and Specifications 13.7.3 Preventice Solutions Mobile Cardiac Telemetry Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Preventice Solutions Main Business Overview 13.7.5 Preventice Solutions Latest Developments 13.8 Telerhythmics LLC 13.8.1 Telerhythmics LLC Company Information 13.8.2 Telerhythmics LLC Mobile Cardiac Telemetry Device Product Portfolios and Specifications 13.8.3 Telerhythmics LLC Mobile Cardiac Telemetry Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Telerhythmics LLC Main Business Overview 13.8.5 Telerhythmics LLC Latest Developments 13.9 Zoll Medical Corporation 13.9.1 Zoll Medical Corporation Company Information 13.9.2 Zoll Medical Corporation Mobile Cardiac Telemetry Device Product Portfolios and Specifications 13.9.3 Zoll Medical Corporation Mobile Cardiac Telemetry Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Zoll Medical Corporation Main Business Overview 13.9.5 Zoll Medical Corporation Latest Developments 13.10 iRhythm Technologies, Inc. 13.10.1 iRhythm Technologies, Inc. Company Information 13.10.2 iRhythm Technologies, Inc. Mobile Cardiac Telemetry Device Product Portfolios and Specifications 13.10.3 iRhythm Technologies, Inc. Mobile Cardiac Telemetry Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 iRhythm Technologies, Inc. Main Business Overview 13.10.5 iRhythm Technologies, Inc. Latest Developments 14 Research Findings and Conclusion